Exploring the potential of combining transcranial magnetic stimulation and electroencephalography to investigate mild cognitive impairment and Alzheimer’s disease: a systematic review
Name:
Revised Manuscript U of A ...
Embargo:
2025-02-15
Size:
668.9Kb
Format:
PDF
Description:
Final Accepted Manuscript
Author
Hall, J. D.Green, Jacob M.
Chen, Yu-Chin A.
Liu, Yilin
Zhang, Hangbin
Sundman, Mark H.
Chou, Ying-hui
Affiliation
Brain Imaging and TMS Laboratory, Department of Psychology, University of ArizonaEvelyn F McKnight Brain Institute, Arizona Center On Aging, and BIO5 Institute, University of Arizona
Issue Date
2024-02-15Keywords
Alzheimer’s diseaseBiomarker
Electroencephalography
Mild cognitive impairment
Transcranial magnetic stimulation
Metadata
Show full item recordPublisher
Springer Science and Business Media LLCCitation
Hall, J.D., Green, J.M., Chen, YC.A. et al. Exploring the potential of combining transcranial magnetic stimulation and electroencephalography to investigate mild cognitive impairment and Alzheimer’s disease: a systematic review. GeroScience (2024). https://doi.org/10.1007/s11357-024-01075-6Journal
GeroScienceRights
© The Author(s), under exclusive licence to American Aging Association 2024.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Transcranial magnetic stimulation (TMS) and electroencephalography (EEG) are non-invasive techniques used for neuromodulation and recording brain electrical activity, respectively. The integration of TMS-EEG has emerged as a valuable tool for investigating the complex mechanisms involved in age-related disorders, such as mild cognitive impairment (MCI) and Alzheimer’s disease (AD). By systematically synthesizing TMS-EEG studies, this review aims to shed light on the neurophysiological mechanisms underlying MCI and AD, while also exploring the practical applications of TMS-EEG in clinical settings. PubMed, ScienceDirect, and PsychInfo were selected as the databases for this review. The 22 eligible studies included a total of 592 individuals with MCI or AD as well as 301 cognitively normal adults. TMS-EEG assessments unveiled specific patterns of corticospinal excitability, plasticity, and brain connectivity that distinguished individuals on the AD spectrum from cognitively normal older adults. Moreover, the TMS-induced EEG features were observed to be correlated with cognitive performance and the presence of AD pathological biomarkers. The comprehensive examination of the existing studies demonstrates that the combination of TMS and EEG has yielded valuable insights into the neurophysiology of MCI and AD. This integration shows great potential for early detection, monitoring disease progression, and anticipating response to treatment. Future research is of paramount importance to delve into the potential utilization of TMS-EEG for treatment optimization in individuals with MCI and AD.Note
12 month embargo; first published 15 February 2024EISSN
2509-2723Version
Final accepted manuscriptSponsors
National Institute on Agingae974a485f413a2113503eed53cd6c53
10.1007/s11357-024-01075-6